Concepedia

Shalev Fried

SF

Statistics

Publications

12

Citations

765

H-Index

11

Active since

2019

Affiliations

Tel Aviv University(Current)

Sheba Medical Center

Memorial Sloan Kettering Cancer Center

Cornell University

Edmond and Lily Safra Children's Hospital

Shalev Fried is an author at Tel Aviv University specializing in oncology, chimeric antigen receptor t-cell therapy, and cancer immunotherapy.

Publications per year

2019–2025

12

Publications

12

Early and late hematologic toxicity following CD19 CAR-T cells

Shalev Fried, Abraham Avigdor, Bella Bielorai et al. · Bone Marrow Transplantation · 2019 · 401 citations

Medicine, Hematology, Immunology +14

Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma

Ana Alarcón Tomás, Joshua Fein, Shalev Fried et al. · Leukemia · 2022 · 102 citations · Full text

Medicine, Hematology, Oncology +13

Patterns of salivary microbiota injury and oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation

Roni Shouval, Adi Eshel, Bar Dubovski et al. · Blood Advances · 2020 · 62 citations · Full text

Dentistry, Microbiology, Oral Biology +17

An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphoma

Sandeep Raj, Teng Fei, Shalev Fried et al. · Nature Medicine · 2025 · 43 citations · Full text

Medicine, Immunology, Oncology +17

Point-of-care anti-CD19 CAR T-cells for treatment of relapsed and refractory aggressive B-cell lymphoma

Meirav Kedmi, Roni Shouval, Shalev Fried et al. · Transplantation and Cellular Therapy · 2022 · 36 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 12